John Rigg

John Rigg serves as Chief Executive Officer at NanoImaging Services since January 2024, following a period of retirement from September 2022 to January 2024. Prior to this, Rigg held various leadership roles, including Chief Executive Officer at Exelead from June 2018 to November 2022, and Vice President & General Manager of Manufacturing at Sigma-tau from June 2014 to June 2018, where responsibilities included overseeing Manufacturing and Quality Operations for Drug Substance and Biologic Drug Products. Rigg also served as Vice President of Manufacturing at Ventria Bioscience and as Senior Director of MS&T at Eli Lilly and Company, managing insulin drug substance processes. Rigg holds a Bachelor of Applied Science in Chemistry from Liverpool John Moores University, with additional education from Iowa State University and St Francis Xavier College Liverpool.